about
Randomised controlled study of clinical efficacy of spacer therapy in asthma with regard to electrostatic chargeSigns and symptoms that precede wheezing in children with a pattern of moderate-to-severe intermittent wheezing.Budesonide for chronic asthma in children and adults.Effect of continuous treatment with topical corticosteroid on episodic viral wheeze in preschool children.A non-electrostatic spacer for aerosol deliveryThe effects of inhaled beclomethasone dipropionate on lung function and histamine responsiveness in recurrently wheezy infantsNebuliser therapy in childhood.Effectiveness of drug treatment strategies to prevent asthma exacerbations and increase symptom-free days in asthmatic children: a network meta-analysis.The Bioavailability of Salbutamol in Urine via Volumatic and Nonvolumatic Valved Holding ChambersCost-utility analysis of the inhaled steroids available in a developing country for the management of pediatric patients with persistent asthma.The role of corticosteroids in respiratory diseases of children.Delivery of inhaled medication to children.Efficacy and safety of inhaled corticosteroids. New developments.Comparable efficacy of administration with face mask or mouthpiece of nebulized budesonide inhalation suspension for infants and young children with persistent asthma.Beclomethasone dipropionate and salbutamol by metered dose inhaler in infants and small children with recurrent wheezing.Changes in body water distribution during treatment with inhaled steroid in pre-school children.Efficacy of fluticasone propionate on lung function and symptoms in wheezy infants.Inhaled corticosteroids in wheezy infants.Efficacy of steroid treatments in the asthmatic preschool child.The effect of inhaled budesonide on symptoms, lung function, and cold air and methacholine responsiveness in 2- to 5-year-old asthmatic children.Bronchoprotection with a leukotriene receptor antagonist in asthmatic preschool children.The Effect of Inhaled Fluticasone Propionate in the Treatment of Young Asthmatic Children
P2860
Q28346185-EBF47FA4-45DF-408E-B629-3C95AC1CD5C7Q30500020-22B4FC72-5141-4D9B-BCDE-FCC12A8461CEQ34424877-CE8E9B9C-22E1-42B2-844C-F3736761A06DQ34796740-81825C80-3618-4884-9963-EFCCA04E6F7CQ34797065-275275AD-6E84-4E10-855A-BAB84EF54246Q34797233-CEA25E8D-05D1-44A3-8AD5-00A5DC3459D1Q35577139-63E4264D-6BC3-491D-B2AF-4E908FFE69DFQ35660168-8F3FC226-3926-4D0B-A558-614B6D287A00Q36370935-DD58289A-2F6E-4BD7-92EF-8C7C240852C9Q38077298-B0A24E89-66D2-47FD-B1DA-DFFA83E8B10BQ41151318-2BECB459-AAB7-42D7-9C20-527603E56CD3Q41680896-2225A479-4979-42CA-AE67-2FF691A4D9E6Q41728966-407C8FFC-FADB-4BA5-84DD-7F335CB22896Q41753582-251B06AD-DD2A-4C40-B60E-32F7AFF5FDEAQ44060729-D9513436-3ED0-4F6C-BD37-616E5888094EQ44942071-5F435BDE-E4F7-4947-8EDD-185417D20356Q45143046-B1ABE809-C67F-4B9B-8D0E-3DDF9173C5DFQ47712458-73C5A102-AE79-420C-B5AD-FCB9748FAC8AQ51701536-49D4D7E8-528A-4E23-97CE-B9551BFB5E26Q54033764-71703C50-5BAD-42CE-8D2A-42576EBDB2D7Q54043857-1B106FFC-17A7-49DD-878B-885972AC9053Q57638329-487AFD43-A136-4EAD-84BC-07AED3B1D3D7
P2860
description
1993 nî lūn-bûn
@nan
1993 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Use of budesonide in severe asthmatics aged 1-3 years.
@ast
Use of budesonide in severe asthmatics aged 1-3 years.
@en
type
label
Use of budesonide in severe asthmatics aged 1-3 years.
@ast
Use of budesonide in severe asthmatics aged 1-3 years.
@en
prefLabel
Use of budesonide in severe asthmatics aged 1-3 years.
@ast
Use of budesonide in severe asthmatics aged 1-3 years.
@en
P2093
P2860
P356
P1476
Use of budesonide in severe asthmatics aged 1-3 years.
@en
P2093
P2860
P304
P356
10.1136/ADC.69.3.351
P407
P577
1993-09-01T00:00:00Z